Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International Consensus (ICON): Drug allergy – Position paper (2014)

●World Allergy Organization (WAO) Special Committee on Drug Allergy: Hypersensitivity reactions to non beta-lactam antimicrobial agents (2013)

Canada

●Canadian Paediatric Society (CPS): Practice point – Beta-lactam allergy in the paediatric population (2020)

United States

●Society of Dermatology Hospitalists (SDH): Supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults (2020)

●Choosing Wisely: Don't overuse non-beta lactam antibiotics with a history of penicillin allergy, without an appropriate evaluation (2014)

●American Academy of Allergy, Asthma, and Immunology (AAAAI), American College of Allergy, Asthma, and Immunology (ACAAI), and Joint Council of Allergy, Asthma, and Immunology (JCAAI): Drug allergy – An updated practice parameter (2010)

Europe

●European Academy of Allergy and Clinical Immunology (EAACI): Task force report on allergy to beta-lactams in children – Clinical entities and diagnostic procedures (2021)

●EAACI: Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD) – A position paper (2019)

●EAACI: Position paper on how to classify cutaneous manifestations of drug hypersensitivity (2019)

●EAACI: Position paper on the investigation of perioperative immediate hypersensitivity reactions (2019)

●EAACI: Towards a more precise diagnosis of hypersensitivity to beta‐lactams – A position paper (2019)

●EAACI/European Network for Drug Allergy (ENDA): Position paper – Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents (2018)

●European Dermatology Forum (EDF) and European Academy of Dermatology and Venereology (EADV): European guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology (2016)

●ENDA/EAACI Drug Allergy Interest Group: Position paper – In vitro tests for drug hypersensitivity reactions (2016)

●ENDA/EAACI Drug Allergy Interest Group: Report from the pediatric task force on drug hypersensitivity in children (2016)

●ENDA/EAACI: Position paper – Drug hypersensitivity in clonal mast cell disorders (2015)

●EAACI Drug Allergy Interest Group: Position paper – Desensitization in delayed drug hypersensitivity reactions (2013)

●ENDA/EAACI Drug Allergy Interest Group: Position paper – Skin test concentrations for systemically administered drugs (2013)

●ENDA/EAACI Interest Group on Drug Hypersensitivity: Position paper – Diagnosis of immediate allergic reactions to beta-lactam antibiotics (2003)

United Kingdom

●Primary Care Dermatology Society (PCDS): Drug rashes – Mild to moderate (2011, updated 2019)

●PCDS: Drug rashes – Severe (2011, updated 2019)

●British Association of Dermatologists (BAD): UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults (2016)

●British Society for Allergy and Clinical Immunology (BSACI): Guideline for the management of allergy to penicillins and other beta-lactams (2015)

●National Institute for Health and Care Excellence (NICE): Quality standard on drug allergy (2015)

●NICE: Clinical guideline on drug allergy – Diagnosis and management (2014)

●Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Drug allergy (2011)

●BSACI: Guidelines for the management of drug allergy (2009)

Australia-New Zealand

●Australasian Society of Clinical Immunology and Allergy (ASCIA): Penicillin allergy – Guide for health professionals (2020)

●Australian and New Zealand Anaesthetic Allergy Group (ANZAAG): Perioperative anaphylaxis investigation guidelines (2017)

●ASCIA: Antibiotic allergy clinical update (2014)